Home Tags RTOR

Tag: RTOR

Ado-trastuzumab emtansine Approved for the Treatment of Early Breast Cancer

In early May 2019, the United States Food and Drug Administration (FDA) approved ado-trastuzumab emtansine (Kadcyla®, Genentech/Roche; T-DM1) for the adjuvant treatment of patients...

X